✦ LIBER ✦

617 E1 therapeutic vaccination in patients with chronic HCV genotype 1 infection: Results of a 15-month, placebo-controlled trial

✍ Scribed by H. Wedemeyer; H. Van Vlierberghe; H. Blum; E. Nevens; M. Gschwantler; S. Zeuzem; T. Roskams; V. Desmet; S. Dincg; C. Vander Stichele; H. De Winter; G. Maertens; Y. Horsmans

Book ID: 117374893
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 109 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80617-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1425 SIMEPREVIR (TMC435) WITH PEGINTERFE

1425 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL

✍ Jacobson, I.; Dore, G.J.; Foster, G.R.; Fried, M.W.; Radu, M.; Rafalskiy, V.V.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Sa2072 Simeprevir (TMC435) With Peginter

Sa2072 Simeprevir (TMC435) With Peginterferon/Ribavirin for Chronic HCV Genotype-1 Infection in Treatment-Nai;auve Patients: Results From QUEST-1, a Phase III Trial

✍ Jacobson, Ira M.; Dore, Gregory J.; Foster, Graham; Fried, Michael W.; Radu, Mon 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 175 KB

1416 FALDAPREVIR PLUS PEGYLATED INTERFER

1416 FALDAPREVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONIC HCV GENOTYPE-1 TREATMENT-NAÏVE PATIENTS: FINAL RESULTS FROM STARTVERSO1, A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL

✍ Ferenci, P.; Asselah, T.; Foster, G.R.; Zeuzem, S.; Sarrazin, C.; Moreno, C.; Ou 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

1413 SIMEPREVIR (TMC435) WITH PEGINTERFE

1413 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL

✍ Manns, M.; Marcellin, P.; Fred Poordad, F.P.; Stanislau Affonso de Araujo, E.; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB

869a Simeprevir (TMC435) With Peginterfe

869a Simeprevir (TMC435) With Peginterferon/Ribavirin for Treatment of Chronic HCV Genotype-1 Infection in Treatment-Naive Patients: Results From QUEST-2, a Phase III Trial

✍ Poordad, Fred; Manns, Michael P.; Marcellin, Patrick; de Araujo, Evaldo Stanisla 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 231 KB

58 FINAL RESULTS – RANDOMIZED, DOUBLE-BL

58 FINAL RESULTS – RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SAFETY, ANTI-VIRAL PROOF-OF-CONCEPT STUDY OF MIRAVIRSEN, AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION

✍ H.W. Reesink; H.L.A. Janssen; S. Zeuzem; E. Lawitz; M. Rodriguez-Torres; K. Pate 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 134 KB